Works by Garattini, Livio
Results: 99
Pharmaceutical policy in Italy.
- Published in:
- 2006
- By:
- Publication type:
- Editorial
Off-patent drugs in Italy.
- Published in:
- European Journal of Health Economics, 2006, v. 7, n. 1, p. 79, doi. 10.1007/s10198-005-0335-9
- By:
- Publication type:
- Article
Direct medical costs of monitoring and treating patients with Takayasu arteritis in Italy.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Direct medical costs unequivocally related to diabetes in Italian specialized centers.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Direct medical costs of age-related macular degeneration in Italian hospital ophthalmology departments. A multicenter, prospective 1-year study.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Comment on: 'NICE, in Confidence: An Assessment of Redaction to Obscure Confidential Information in Single Technology Appraisals by the National Institute for Health and Care Excellence'.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Comment on: 'The Impact of Hospital Costing Methods on Cost-Effectiveness Analysis: A Case Study'.
- Published in:
- 2019
- By:
- Publication type:
- Letter
Performance-Based Agreements in Italy: 'Trendy Outcomes' or Mere Illusions?
- Published in:
- 2016
- By:
- Publication type:
- journal article
Pharmaceutical Price Schemes in Europe: Time for a 'Continental' One?
- Published in:
- 2016
- By:
- Publication type:
- journal article
Economic Evidence of Pneumococcal Vaccination in Older Adults: Uncertain Modelling or Competitive Tendering?
- Published in:
- 2016
- By:
- Publication type:
- journal article
Cost-Effectiveness Modeling in Multiple Sclerosis: Playing Around with Non-Healthcare Costs?
- Published in:
- 2015
- By:
- Publication type:
- journal article
Cost Effectiveness of the New Pneumococcal Vaccines: A Systematic Review of European Studies.
- Published in:
- PharmacoEconomics, 2014, v. 32, n. 1, p. 29, doi. 10.1007/s40273-013-0113-y
- By:
- Publication type:
- Article
The burden of moderate to severe psoriasis: an overview.
- Published in:
- 2012
- By:
- Publication type:
- journal article
The Burden of Moderate to Severe Psoriasis.
- Published in:
- PharmacoEconomics, 2012, v. 30, n. 11, p. 1005, doi. 10.2165/11591580-000000000-00000
- By:
- Publication type:
- Article
The Authors' Reply.
- Published in:
- 2012
- By:
- Publication type:
- Letter
Pricing Human Papillomavirus Vaccines Lessons from Italy.
- Published in:
- 2012
- By:
- Publication type:
- Opinion
Medical Costs of Glaucoma and Ocular Hypertension in Italian Referral Centres: A Prospective Study.
- Published in:
- Ophthalmologica, 2007, v. 221, n. 5, p. 340, doi. 10.1159/000104765
- By:
- Publication type:
- Article
Medical Costs of Chronic Musculoskeletal Pain in Italy.
- Published in:
- Clinical Drug Investigation, 2007, v. 27, n. 2, p. 139, doi. 10.2165/00044011-200727020-00007
- By:
- Publication type:
- Article
Public regulation of private pharmacies in the European Union: time for a logical solution for retail distribution.
- Published in:
- Internal & Emergency Medicine, 2024, v. 19, n. 6, p. 1525, doi. 10.1007/s11739-024-03691-8
- By:
- Publication type:
- Article
A European National Health and Social Service model: the S of social.
- Published in:
- Internal & Emergency Medicine, 2024, v. 19, n. 1, p. 233, doi. 10.1007/s11739-023-03483-6
- By:
- Publication type:
- Article
A European national health and social service model: imagining a rational philosophy for health care organizations.
- Published in:
- Internal & Emergency Medicine, 2023, v. 18, n. 8, p. 2435, doi. 10.1007/s11739-023-03409-2
- By:
- Publication type:
- Article
A European national health and social service model: a rational network of health care facilities.
- Published in:
- Internal & Emergency Medicine, 2023, v. 18, n. 6, p. 1855, doi. 10.1007/s11739-023-03342-4
- By:
- Publication type:
- Article
A European national health and social service model: a few rules of the game.
- Published in:
- Internal & Emergency Medicine, 2023, v. 18, n. 5, p. 1583, doi. 10.1007/s11739-023-03301-z
- By:
- Publication type:
- Article
The role of general practitioners in the EU: time to draw lessons from a too wide range?
- Published in:
- Internal & Emergency Medicine, 2023, v. 18, n. 2, p. 343, doi. 10.1007/s11739-023-03205-y
- By:
- Publication type:
- Article
Why so many different specialty training programmes in general practice in Europe?
- Published in:
- 2022
- By:
- Publication type:
- journal article
Pharmaceutical pricing in Europe: time to take the right direction.
- Published in:
- Internal & Emergency Medicine, 2022, v. 17, n. 4, p. 945, doi. 10.1007/s11739-022-02960-8
- By:
- Publication type:
- Article
Pharmaceutical patenting in the European Union: reform or riddance.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Integrated care: easy in theory, harder in practice?
- Published in:
- Internal & Emergency Medicine, 2022, v. 17, n. 1, p. 3, doi. 10.1007/s11739-021-02830-9
- By:
- Publication type:
- Article
The Italian NHS in Lombardy and Veneto: near but far.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Community and hospital pharmacists in Europe: encroaching on medicine?
- Published in:
- Internal & Emergency Medicine, 2021, v. 16, n. 1, p. 7, doi. 10.1007/s11739-020-02496-9
- By:
- Publication type:
- Article
Conflicts of interest in medicine: a never-ending story.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Economic evaluation of human papilloma virus vaccination in the European Union: a critical review.
- Published in:
- Internal & Emergency Medicine, 2011, v. 6, n. 2, p. 163, doi. 10.1007/s11739-011-0529-3
- By:
- Publication type:
- Article
Utilities and QALYs in health economic evaluations: glossary and introduction.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Pharmaceutical Patents in Europe: Radical Reforms Rather Than Getting Rid?
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Integrated Care in Europe: Time to Get it Together?
- Published in:
- 2022
- By:
- Publication type:
- Editorial
The Italian NHS: What Lessons to Draw from COVID-19?
- Published in:
- Applied Health Economics & Health Policy, 2020, v. 18, n. 4, p. 463, doi. 10.1007/s40258-020-00594-5
- By:
- Publication type:
- Article
Comment on: 'Value-Based Pricing Alternatives for Personalised Drugs: Implications of Asymmetric Information and Competition'.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Pricing of HPV Vaccines in Europe: Back to the Future?
- Published in:
- Applied Health Economics & Health Policy, 2018, v. 16, n. 3, p. 275, doi. 10.1007/s40258-018-0375-9
- By:
- Publication type:
- Article
Multiple Criteria Decision Analysis in Health Technology Assessment for Drugs: Just Another Illusion?
- Published in:
- Applied Health Economics & Health Policy, 2018, v. 16, n. 1, p. 1, doi. 10.1007/s40258-017-0345-7
- By:
- Publication type:
- Article
Clinical Governance in Italy: 'Made in England' for Import?
- Published in:
- Applied Health Economics & Health Policy, 2017, v. 15, n. 5, p. 541, doi. 10.1007/s40258-017-0328-8
- By:
- Publication type:
- Article
'Appropriateness' in Italy: A 'Magic Word' in Pharmaceuticals?
- Published in:
- Applied Health Economics & Health Policy, 2017, v. 15, n. 1, p. 1, doi. 10.1007/s40258-016-0240-7
- By:
- Publication type:
- Article
Safety and Quality of Generic Drugs: A Never Ending Debate Fostered by Economic Interests?
- Published in:
- Applied Health Economics & Health Policy, 2015, v. 13, p. 3, doi. 10.1007/s40258-015-0156-7
- By:
- Publication type:
- Article
Biosimilar Versus Generic Drugs: Same But Different?
- Published in:
- Applied Health Economics & Health Policy, 2015, v. 13, n. 2, p. 125, doi. 10.1007/s40258-015-0154-9
- By:
- Publication type:
- Article
Comment on: 'Current Status and Trends in Performance-Based Risk-Sharing Arrangements Between Healthcare Payers and Medical Product Manufacturers'.
- Published in:
- Applied Health Economics & Health Policy, 2014, v. 12, n. 5, p. 565, doi. 10.1007/s40258-014-0118-5
- By:
- Publication type:
- Article
Dutch guidelines for economic evaluation: 'from good to better' in theory but further away from pharmaceuticals in practice?
- Published in:
- 2017
- By:
- Publication type:
- journal article
Cholesterol-lowering drugs: science and marketing.
- Published in:
- 2017
- By:
- Publication type:
- journal article
European Medicines Agency: leave the UK but remain the same.
- Published in:
- 2016
- By:
- Publication type:
- Editorial
Market-access agreements for anti-cancer drugs.
- Published in:
- Journal of the Royal Society of Medicine, 2015, v. 108, n. 5, p. 166, doi. 10.1177/0141076814559626
- By:
- Publication type:
- Article
Tendering and value-based pricing: lessons from Italy on human papilloma virus vaccines.
- Published in:
- Journal of the Royal Society of Medicine, 2014, v. 107, n. 1, p. 4, doi. 10.1177/0141076813512122
- By:
- Publication type:
- Article
Obesity epidemic in European countries: from an unaddressed risk factor to a medicalized disease?
- Published in:
- European Journal of Health Economics, 2025, v. 26, n. 1, p. 1, doi. 10.1007/s10198-024-01752-5
- By:
- Publication type:
- Article